Evidence map›Paper›PMID 33442000›Full record

ReviewNature reviews. Genetics2021

Enhancer redundancy in development and disease.

Evgeny Z Kvon, Rachel Waymack, Mario Gad, Zeba Wunderlich

Erratum issuedOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 151 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed, 1 pooled it
19.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed, 1 synthesis or guideline pooled it, 258 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Temporal loss ofGenes & development · 2026
    Article
  16. Article
  17. Review
  18. Enhancer hubs govern chromatin topology and Th17 cell identity.bioRxiv : the preprint server for biology · 2026
    Article
  19. Article
  20. Article

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Evgeny Z Kvon *Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA. ekvon@uci.edu.ORCID http://orcid.org/0000-0002-1562-0945
Rachel WaymackDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA.ORCID http://orcid.org/0000-0002-8324-0282
Mario GadDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA.
Zeba Wunderlich *Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA. zeba@uci.edu.ORCID http://orcid.org/0000-0003-4491-5715
University of California, Irvine · US

Funding

Mechanisms of shadow enhancer robustness during developmentR01HD095246 · NICHD · UNIVERSITY OF CALIFORNIA-IRVINE · PI Zeba B Wunderlich · 2018 to 2026
$2.7M
Functional assessment of enhancer-gene interactions in vivoR00HG009682 · NHGRI · UNIVERSITY OF CALIFORNIA-IRVINE · PI KVON, EVGENY · 2020 to 2022
$736k
NHGRI NIH HHS R00 HG009682NICHD NIH HHS R01 HD095246
6 · The paper itself

Abstract

Shadow enhancers are seemingly redundant transcriptional cis-regulatory elements that regulate the same gene and drive overlapping expression patterns. Recent studies have shown that shadow enhancers are remarkably abundant and control most developmental gene expression in both invertebrates and vertebrates, including mammals. Shadow enhancers might provide an important mechanism for buffering gene expression against mutations in non-coding regulatory regions of genes implicated in human disease. Technological advances in genome editing and live imaging have shed light on how shadow enhancers establish precise gene expression patterns and confer phenotypic robustness. Shadow enhancers can interact in complex ways and may also help to drive the formation of transcriptional hubs within the nucleus. Despite their apparent redundancy, the prevalence and evolutionary conservation of shadow enhancers underscore their key role in emerging metazoan gene regulatory networks.

Indexed as

Enhancer Elements, GeneticGene Expression Regulation, DevelopmentalAnimalsDrosophila melanogasterGene Regulatory NetworksHumans

Identifiers

PMID33442000
PMCPMC8068586
OpenAlexW3119327744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.